Evidence map›Paper›PMID 40873503›Full record

ArticleTransboundary and emerging diseases2025

Analysis of Genetic Diversity Based on Sequences of Feline Calicivirus Strains Isolated in China.

Yupeng Yang, Mengru Chen, Zhe Liu, Kexin Feng, Ruibin Qi, Hongtao Kang, Qian Jiang, Liandong Qu, Jiasen Liu

Abstract read
In one paragraph

Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yupeng YangState Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Mengru ChenCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China.
Zhe LiuState Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Kexin FengState Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Ruibin QiState Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Hongtao KangState Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Qian JiangState Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Liandong QuState Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.ORCID https://orcid.org/0000-0003-4633-069X
Jiasen LiuState Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.ORCID https://orcid.org/0000-0002-7441-3663

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, feline calicivirus (FCV) has caused increasingly severe harm in China, posing a significant threat to feline health. However, our understanding of the complex epidemiology and genetic diversity of FCV in China remains limited. In this study, we integrated various bioinformatics methods and used isolates from China as the primary research subjects. The approach ranged from basic prevalence statistics to genome sequence analysis, systematic exploration of spatiotemporal evolution, recombination studies, comparisons of specific sites, structural biology predictions, protein adaptation analysis, and molecular dynamics simulations. This comprehensive approach aimed to obtain a thorough understanding of the characteristics of FCV in China. An in-depth analysis of the results indicates that FCV exhibits a nationwide epidemic trend in China mainly consisting of two genotypes: GI and GII. The prevalence rate of genotype GI exceeds 70%, making it the predominant epidemic genotype. Spatiotemporal evolution predicts that the ancestor of genotype GI emerged in 1821 while the ancestor of genotype GII emerged in 1879. After the 1950s, there was rapid expansion in the spread of FCV which extended from eastern parts to regions in southwest, southeast, and northeast after 1990. The analysis on recombinant evolution suggests that FCV can undergo recombination within same genotypes or across different genotypes enhancing its cross-species transmission and infectivity capabilities. Amino acid sequence analysis reveals mutations at key amino acid site position 481 involved in receptor binding where K mutated into E or N in domestic prevalent strains recently. All seven amino acid sites related virulence have undergone mutations. The results of protein adaptability analysis indicate that the amino acid residue at position 281 (N) in the VP1 protein is a site of adaptive selection. In some strains, the amino acid at this position has mutated from N to G, S, or R. Further molecular dynamics simulations reveal that these mutations affect the structural stability of the VP1 protein. The results of this study are essential for gaining a thorough understanding of the FCV profile in China and can be used to create better prevention and control strategies.

Indexed as

Caliciviridae InfectionsCalicivirus, FelineCat DiseasesGenetic VariationAnimalsCatsChinaGenotypePhylogenyfeline calicivirusgenetic diversitygenotypesmutationsprotein adaptability analysisrecombinationspatiotemporal evolutionVP1 protein

Identifiers

PMID40873503
PMCPMC12380517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.